Home prices have stopped soaring. Here’s where growth has slowed the most.
Record-high home prices might be coming down, but a real-estate crash isn’t on the horizon, one economist said.
Record-high home prices might be coming down, but a real-estate crash isn’t on the horizon, one economist said.
Amazon has long defied convention by showing relatively low profits as it has invested heavily to expand its business. But the recent broad stock-market decline emphasizes an interesting change.
A 65-year-old retiring this year can expect to spend an average of $165,000 on healthcare and medical expenses during their retirement — up nearly 5% from a year ago and more than double the forecast in 2002, according to Fidelity Investments.
The 30-year mortgage rate is averaging 6.47%, Freddie Mac said in its latest weekly survey on Thursday.
The investing app plans to roll out futures trading and a new platform for desktop.
A post-data extended selloff in U.S. government debt took hold on Thursday, pushing the benchmark 10-year Treasury yield above or near 4% for the first time in about a week. And stock investors seem fine with that.
Curaleaf Holdings Inc. said its co-founder and executive chair Boris Jordan will add the role of chief executive of the country’s largest legal-cannabis business after Matt Darin steps down after two years in the job.
Yeti’s stock was having its best day in a year on Thursday, after the outdoor-products maker reported second-quarter earnings that rose above expectations, boosted by record cooler sales.
Analysts are always looking for historical parallels to current conditions. In a new note, UBS points to the third quarter of 2011..
Revenue remains about flat at $184 million
One analyst notes “a legitimate uplift in demand for fiber infrastructure to support the growth in AI” — but short covering is likely also at play with shares up 500% in a month.
Under Armour Inc.’s stock rose 7.7% premarket Thursday after the athletic-apparel maker beat Wall Street’s top and bottom-line expectations in its first-quarter results and raised its earnings outlook.
Sandoz, the generics drugmaker spun off from Novartis, is going to get into making cheap versions of the wildly popular GLP-1 class of drugs to treat diabetes and weight loss. But it may take a while.
No banking or credit card information was included in the theft
The number of Americans who applied for unemployment benefits last week fell sharply to 233,000 and receded from a nearly one-year high, suggesting layoffs remain quite low and that the labor market is still in good shape.
Selloff creates cast-offs to jump on.
The company’s stock climbed 6% in premarket trading.
Eli Lilly’s stock was headed for its best day in a year on Thursday, after the drugmaker reported second-quarter earnings that rose well above forecasts, amid strength in sales of its diabetes and obesity treatments, Mounjaro and Zepbound.
The board of the Texas real estate-company confirms there’s an offer from billionaire’s hedge fund.
The green hydrogen company also reported a bigger loss than analysts were expecting.